<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <createDate>2018-04-24T04:26:06Z</createDate>
    <amendments />
    <titles>
      <item>
        <chamberCode />
        <title>A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.</title>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Addiction Prevention and Responsible Opioid Practices Act</title>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Addiction Prevention and Responsible Opioid Practices Act</title>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Addiction Prevention and Responsible Opioid Practices Act</title>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
    </titles>
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2018-04-23T04:00:00Z</updateDate>
          <lastSummaryUpdateDate>2019-08-01T21:26:30Z</lastSummaryUpdateDate>
          <name>Introduced in Senate</name>
          <actionDesc>Introduced in Senate</actionDesc>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><strong>Addiction Prevention and Responsible Opioid Practices Act</strong></p> <p>This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.</p>]]></text>
          <actionDate>2018-04-23</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <notes />
    <billNumber>2729</billNumber>
    <congress>115</congress>
    <title>Addiction Prevention and Responsible Opioid Practices Act</title>
    <billType>S</billType>
    <cosponsors />
    <cboCostEstimates />
    <textVersions>
      <item>
        <date>2018-04-23T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s2729is/xml/BILLS-115s2729is.xml</url>
          </item>
        </formats>
        <type>Introduced in Senate</type>
      </item>
    </textVersions>
    <sponsors>
      <item>
        <middleName>J.</middleName>
        <lastName>DURBIN</lastName>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <identifiers>
          <bioguideId>D000563</bioguideId>
          <gpoId>8326</gpoId>
          <lisID>326</lisID>
        </identifiers>
        <bioguideId>D000563</bioguideId>
        <firstName>RICHARD</firstName>
        <state>IL</state>
        <party>D</party>
        <byRequestType />
      </item>
    </sponsors>
    <relatedBills>
      <item>
        <congress>115</congress>
        <latestAction>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
          <actionDate>2018-07-24</actionDate>
        </latestAction>
        <number>5865</number>
        <type>HR</type>
        <latestTitle>Addiction Prevention and Responsible Opioid Practices Act</latestTitle>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2018-04-23</actionDate>
        <committee>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
        </committee>
        <links>
          <link>
            <url>https://www.congress.gov/congressional-record/volume-164/senate-section/page/S2343-2346</url>
            <name>S2343-2346</name>
          </link>
        </links>
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2018-04-23</actionDate>
        <committee />
        <actionCode>10000</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <links />
        <text>Introduced in Senate</text>
      </item>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <recordedVotes />
    <originChamber>Senate</originChamber>
    <committeeReports />
    <version>1.0.0</version>
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssfi00</systemCode>
          <activities>
            <item>
              <date>2018-04-23T22:48:50Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <name>Finance Committee</name>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <calendarNumbers />
    <laws />
    <updateDate>2019-10-18T16:08:07Z</updateDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Alternative treatments</name>
          </item>
          <item>
            <name>Business ethics</name>
          </item>
          <item>
            <name>Business records</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Government studies and investigations</name>
          </item>
          <item>
            <name>Health care quality</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Hospital care</name>
          </item>
          <item>
            <name>Indian social and development programs</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Medical education</name>
          </item>
          <item>
            <name>Medical ethics</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Military medicine</name>
          </item>
          <item>
            <name>Minority health</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Sales and excise taxes</name>
          </item>
          <item>
            <name>State and local government operations</name>
          </item>
          <item>
            <name>User charges and fees</name>
          </item>
          <item>
            <name>Veterans' medical care</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <introducedDate>2018-04-23</introducedDate>
    <latestAction>
      <links />
      <actionDate>2018-04-23</actionDate>
      <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

